The K65R mutant reverse transcriptase of HIV-1 cross-resistant to 2', 3'-dideoxycytidine, 2',3'-dideoxy-3'-thiacytidine, and 2',3'-dideoxyinosine shows reduced sensitivity to specific dideoxynucleoside triphosphate inhibitors in vitro.

This publication has 25 references indexed in Scilit:

• Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine
  Antimicrobial Agents and Chemotherapy, 1994
• Crystal Structure at 3.5 Å Resolution of HIV-1 Reverse Transcriptase Complexed with an Inhibitor
  Science, 1992
• Factors contributing to the inhibition of HIV reverse transcriptase by chain‐terminating nucleotides in vitro and in vivo
  FEBS Letters, 1991
• Resistance to ddI and Sensitivity to AZT Induced by a Mutation in HIV-1 Reverse Transcriptase
  Science, 1991
• Characterization of Reverse Transcriptase Activity and Susceptibility to Other Nucleosides of AZT‐Resistant Variants of HIV‐1
  Annals of the New York Academy of Sciences, 1990
• HIV-1 Reverse Transcriptase Purified from a Recombinant Strain ofEscherichia coli
  AIDS Research and Human Retroviruses, 1990
• Denaturation/Refolding of Purified Recombinant HIV Reverse Transcriptase Yields Monomeric Enzyme with High Enzymatic Activity
  AIDS Research and Human Retroviruses, 1990
• Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)
  Science, 1989
• Characterization of Highly Immunogenic p66/p51 as the Reverse Transcriptase of HTLV-III/LAV
  Science, 1986
• Characterization of the RNA dependent DNA polymerase of a new human T lymphotropic retrovirus (lymphadenopathy associated virus)
  Biochemical and Biophysical Research Communications, 1984